Dr. DiLena uses biologic grafts in the majority of his pelvic procedures, including hysterectomies, myomectomies, endometriosis excisions, ovarian cystectomies, C-sections, and other procedures involving pelvic tissue dissection and reconstruction. Rather than focusing on the procedure itself, he evaluates the amount of tissue trauma and the resulting healing response.
Any time tissue is cut, cauterized, dissected, or manipulated during surgery, the body initiates a healing response. That healing process can contribute to inflammation, fibrosis, and adhesion formation regardless of whether the procedure is routine or complex.
Dr. DiLena incorporates biologic grafts as part of his strategy to support healthy tissue healing following surgery. His goal is to help create an optimal healing environment, reduce excessive fibrosis, minimize adhesion formation, and ultimately support better long-term patient outcomes.
One of the primary reasons Dr. DiLena began exploring biologic grafts was the ongoing challenge of adhesion formation in pelvic surgery. Even with meticulous surgical technique, adhesions can still develop following tissue manipulation, inflammation, endometriosis surgery, and repeat procedures. Biologic grafts became part of his strategy to help support healthier tissue healing and reduce the factors that contribute to excessive scar tissue formation.
Dr. DiLena wanted a solution that did more than simply create a temporary physical barrier. By supporting the healing environment at the tissue level, he observed trends in his own practice that included faster recovery, reduced post-operative discomfort, fewer complications, and improved overall patient recovery. While outcomes vary by patient and procedure, these clinical observations contributed significantly to his continued use of biologic grafts.
In fertility-focused surgery, optimizing healing is critical. Adhesion formation, fibrosis, and scar tissue can all impact long-term reproductive outcomes. Dr. DiLena incorporates biologic grafts as part of his approach to help support healthy tissue healing, preserve normal anatomy, and optimize recovery in patients where fertility preservation is an important consideration.
Dr. DiLena routinely incorporates biologic grafts into a wide range of pelvic procedures, including hysterectomies, myomectomies, endometriosis excisions, ovarian cystectomies, C-sections, and other procedures involving pelvic tissue dissection and reconstruction. Rather than limiting biologics to specific cases, he evaluates each procedure based on its potential impact on tissue healing.
Any time tissue is cut, cauterized, dissected, or manipulated during surgery, the body initiates a healing response. That response can lead to inflammation, fibrosis, and adhesion formation regardless of the specific procedure being performed. According to Dr. DiLena, the tissue responds to surgical trauma—not the procedure name or billing code.
Dr. DiLena views biologic grafts as a tool for supporting healthy tissue healing after surgery. His goal is to help create an optimal healing environment, reduce excessive fibrosis, minimize adhesion formation, and support better long-term patient outcomes. For this reason, biologic grafts have become a routine part of his approach in the majority of his pelvic procedures.